Skip to main content

Weather alert

Due to winter storm Fern, our Patient Service Centers in affected areas may be closed. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational. For site-specific information, please use Find a location and enter your zip code.

Hide
Quest Diagnostics

Utility of Hereditary Cancer Panel Testing in Individuals With a Known Familial Variant

CCGGC 2023

11th Annual City of Hope and University of Chicago Clinical Cancer Genetics and Genomics Conference, University of Chicago 

Universal City, CA, May 5-7, 2023

Poster presentation: Utility of hereditary cancer panel testing in individuals with a known familial variant

Authors: Weltmer E, O’Brien K, Johnson R, Terhaar C, Fesko Y

Specialties: Oncology, Genetics

Related content

Test FAQ
Guideline based Hereditary Cancer Panel
Test FAQ
Comprehensive Hereditary Cancer Panel
Test FAQ
Hereditary Cancer Single Site(s)
On-Demand Webinar
Hereditary Cancer Care Starts in Primary Care
Audio Podcast
Molecular Expression Through the Eyes of the Pathologist and Oncologist
Audio Podcast
Optimize Oncology Care with Clinical Pathways

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.